معرفی
Wei Gao is an Assistant Professor of Pharmacology at the University of Houston College of Pharmacy, specializing in the Department of Pharmacological and Pharmaceutical Sciences. With a focus on nanomedicine and immunotherapy, Dr. Gao develops innovative strategies to modulate B cells and myeloid cells for treating cancer and immune diseases.
- B.S., School of Life Science and Technology, China Pharmaceutical University
- Master, School of Pharmacy, University of Calabria, Italy
- M.S. in Pharmaceutics, China Pharmaceutical University
- Ph.D. in Pharmaceutics, Peking University Health Science Center
- Postdoctoral Research Fellow (2017-2021) and Assistant Research Scientist (2022-2024), University of Michigan College of Pharmacy
Dr. Gao’s research emphasizes nanovaccine development and overcoming STING pathway resistance in pancreatic cancer through regulatory B cell elimination. His work also explores albumin-based nanoformulations for lymphatic system targeting. Recent publications highlight advancements in tumor microenvironment-responsive nanoparticles, multidrug resistance reversal, and combinatorial immunotherapy strategies.
Dr. Gao is a co-investigator on the NIH R01 CA285790-01 grant (2024-2029) and a member of the American Association for Cancer Research, Controlled Release Society, American Association of Pharmaceutical Scientists, and Society for Immunotherapy of Cancer.
